AROVELLA THERAPEUTICS LIMITED - Announcements

4.76%

10.0¢

Market Cap $119.2M

Healthcare Biotechnology

Arovella Therapeutics Limited is a biotechnology company. The Company is focused on... Arovella Therapeutics Limited is a biotechnology company. The Company is focused on developing its invariant natural killer T (iNKT) cell therapy platform from Imperial College London to treat blood cancers and solid tumors. The Company's lead product is ALA-101. ALA-101 is being developed as an allogeneic cell therapy, which means it can be given from a healthy donor to a patient. ALA-101 is a next-generation CAR-iNKT cell therapy that targets CD19+ B cell lymphomas and leukemias. ALA-101 consists of CAR19-iNKT cells that have been modified to produce a Chimeric Antigen Receptor (CAR) that targets CD19. CD19 is an antigen found on the surface of numerous cancer types. The Company is also engaged in expanding solid tumor treatment through its CLDN18.2-targeting technology licensed from Sparx Group. Its iNKT cells also contain an invariant T cell receptor (iTCR) that targets alpha-galactosylceramide (a-GalCer) bound CD1d, another antigen found on the surface of several cancer types.More

HELPING PATIENTS ON THEIR JOURNEY TO BETTER HEALTH

Little Green Pharma (ASX:LGP) to benefit as Denmark commits to cannabis pilot program.

Announcements

Filter Results

All Price Sensitive Only

ALA	Notice Under Section 708A		07/08/25	212.33KB	Share
ALA	Application for quotation of securities - ALA		07/08/25	15.61KB	Share
ALA	Notice Under Section 708A		04/08/25	212.05KB	Share
ALA	Application for quotation of securities - ALA		04/08/25	15.67KB	Share
ALA	Proposed issue of securities - ALA		01/08/25	15.18KB	Share
ALA	Investor Presentation		28/07/25	3.94MB	Share
ALA	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/07/25	720.46KB	Share
ALA	Notification regarding unquoted securities - ALA		16/07/25	15.75KB	Share
ALA	Notification of cessation of securities - ALA		07/07/25	12.75KB	Share
ALA	Investor Presentation		02/07/25	3.31MB	Share
ALA	Final Director's Interest Notice		01/07/25	254.77KB	Share
ALA	Notice Under Section 708A		30/06/25	212.19KB	Share
ALA	Retirement of Non-Executive Chairman		30/06/25	198.51KB	Share
ALA	Application for quotation of securities - ALA		27/06/25	15.5KB	Share
ALA	Notice Under Section 708A		24/06/25	252.11KB	Share
ALA	Application for quotation of securities - ALA		23/06/25	15.49KB	Share
ALA	Notice Under Section 708A		17/06/25	212.3KB	Share
ALA	Notification of cessation of securities - ALA		17/06/25	12.88KB	Share
ALA	Notification of cessation of securities - ALA		17/06/25	12.88KB	Share
ALA	Notification of cessation of securities - ALA		17/06/25	12.88KB	Share
ALA	Application for quotation of securities - ALA		17/06/25	15.79KB	Share
ALA	Application for quotation of securities - ALA		17/06/25	15.79KB	Share
ALA	Application for quotation of securities - ALA		17/06/25	15.8KB	Share
ALA	Results of Extraordinary General Meeting		08/05/25	216.56KB	Share
ALA	ALA exclusive iNKT technology option with Baylor		05/05/25	253.69KB	Share
ALA	Investor webinar presentation		29/04/25	3.66MB	Share
ALA	Notification regarding unquoted securities - ALA		24/04/25	16.44KB	Share
ALA	Quarterly Update Webinar		16/04/25	182.74KB	Share
ALA	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	16/04/25	790.01KB	Share
ALA	Notice of Extraordinary General Meeting/Proxy Form		10/04/25	896.41KB	Share
ALA	Cancel - Proposed issue of securities - ALA		01/04/25	14.87KB	Share
ALA	Cancel - Proposed issue of securities - ALA		01/04/25	14.88KB	Share
ALA	Notification of cessation of securities - ALA		27/03/25	12.84KB	Share
ALA	Quotation of Options		26/03/25	234.73KB	Share
ALA	Application for quotation of securities - ALA		26/03/25	16.7KB	Share
ALA	Proposed issue of securities - ALA		26/03/25	14.83KB	Share
ALA	Prospectus		26/03/25	391.66KB	Share
ALA	S&P DJI Announces March 2025 Quarterly Rebalance	PRICE SENSITIVE	07/03/25	174.42KB	Share
ALA	Top 20 Holders and Range of Units for Attaching Options		05/03/25	82.61KB	Share
ALA	Application for quotation of securities - ALA		05/03/25	19.09KB	Share
ALA	Application for quotation of securities - ALA		05/03/25	15.75KB	Share
ALA	Research Agreement with University of North Carolina	PRICE SENSITIVE	03/03/25	198.83KB	Share
ALA	Letter from Managing Director and CEO		03/03/25	131.35KB	Share
ALA	Half Year Report and Appendix 4D	PRICE SENSITIVE	27/02/25	3.35MB	Share
ALA	Reinstatement to Official Quotation	PRICE SENSITIVE	26/02/25	85.89KB	Share
ALA	Proposed issue of securities - ALA		26/02/25	14.82KB	Share
ALA	Proposed issue of securities - ALA		26/02/25	16.52KB	Share
ALA	Cancel - Proposed issue of securities - ALA		26/02/25	15.48KB	Share
ALA	Prospectus	PRICE SENSITIVE	26/02/25	391.86KB	Share
ALA	Arovella $15m Placement to fund Phase 1	PRICE SENSITIVE	26/02/25	274.83KB	Share
ALA	Voluntary Suspension	PRICE SENSITIVE	10/02/25	718.43KB	Share
ALA	Trading Halt	PRICE SENSITIVE	06/02/25	268.69KB	Share
ALA	Notification of cessation of securities - ALA		04/02/25	12.84KB	Share
ALA	Application for quotation of securities - ALA		04/02/25	15.57KB	Share
ALA	Investor Presentation - Euroz Hartleys Healthcare Forum		04/02/25	3.54MB	Share
ALA	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/25	613.43KB	Share
ALA	Update - Proposed issue of securities - ALA		30/01/25	15.37KB	Share
ALA	Notice Under Section 708A		20/01/25	684.91KB	Share
ALA	Application for quotation of securities - ALA		20/01/25	15.56KB	Share
ALA	Notice Under Section 708A		14/01/25	176.33KB	Share
ALA	Application for quotation of securities - ALA		14/01/25	15.56KB	Share
ALA	Proposed issue of securities - ALA		10/01/25	15.42KB	Share
ALA	Arovella $20m Placement - fully funded to complete Phase 1	PRICE SENSITIVE	10/01/25	267.39KB	Share
ALA	Trading Halt	PRICE SENSITIVE	08/01/25	789.72KB	Share
ALA	Release of Shares from Escrow		06/12/24	667.18KB	Share
ALA	Change of Director's Interest Notice x5		29/11/24	876.7KB	Share
ALA	Notification regarding unquoted securities - ALA		26/11/24	16.9KB	Share
ALA	Notice Under Section 708A		15/11/24	213.96KB	Share
ALA	Application for quotation of securities - ALA		15/11/24	15.56KB	Share
ALA	Results of Annual General Meeting		15/11/24	219.36KB	Share
ALA	AGM Chairman's Address and CEO & MD Presentation		15/11/24	3.17MB	Share
ALA	Notice Under Section 708A		13/11/24	213.17KB	Share
ALA	Application for quotation of securities - ALA		13/11/24	15.57KB	Share
ALA	AusBioInvest Presentation		29/10/24	2.48MB	Share
ALA	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	29/10/24	958.06KB	Share
ALA	Arovella receives R&D tax rebate of $3.0 million	PRICE SENSITIVE	25/10/24	196.37KB	Share
ALA	Notice Under Section 708A		24/10/24	214.15KB	Share
ALA	Application for quotation of securities - ALA		24/10/24	15.56KB	Share
ALA	Notice Under Section 708A		18/10/24	213.21KB	Share
ALA	Application for quotation of securities - ALA		18/10/24	15.56KB	Share
ALA	Notice Under Section 708A		16/10/24	213.17KB	Share
ALA	Application for quotation of securities - ALA		16/10/24	15.56KB	Share
ALA	Investor Presentation		16/10/24	4.75MB	Share
ALA	Clinical Advisory Board established		14/10/24	238.64KB	Share
ALA	Notice of Annual General Meeting/Proxy Form		09/10/24	741.68KB	Share
ALA	Notification regarding unquoted securities - ALA		07/10/24	15.71KB	Share
ALA	Release of Shares from Escrow		01/10/24	231.97KB	Share
ALA	Notification regarding unquoted securities - ALA		19/09/24	16.82KB	Share
ALA	Application for quotation of securities - ALA		19/09/24	17.7KB	Share
ALA	Investor Webinar Presentation		18/09/24	3.8MB	Share
ALA	Becoming a substantial holder		18/09/24	164.73KB	Share
ALA	Change in substantial holding		18/09/24	194.55KB	Share
ALA	Updated Investor Webinar Presentation		12/09/24	239.74KB	Share
ALA	Investor Webinar Presentation		12/09/24	237.06KB	Share
ALA	2024 ESG Report		11/09/24	405.46KB	Share
ALA	ALA presents at Cell and Gene Therapy World Asia Conference		10/09/24	3.61MB	Share
ALA	Corporate Governance Statement		22/08/24	209.37KB	Share
ALA	Appendix 4G		22/08/24	268.71KB	Share
ALA	Appendix 4E and Annual Report	PRICE SENSITIVE	22/08/24	5.2MB	Share
ALA	Positive pre-IND feedback from FDA for ALA-101	PRICE SENSITIVE	07/08/24	203.16KB	Share

ALA Notice Under Section 708A
07/08/25		212.33KB	Share
ALA Application for quotation of securities - ALA
07/08/25		15.61KB	Share
ALA Notice Under Section 708A
04/08/25		212.05KB	Share
ALA Application for quotation of securities - ALA
04/08/25		15.67KB	Share
ALA Proposed issue of securities - ALA
01/08/25		15.18KB	Share
ALA Investor Presentation
28/07/25		3.94MB	Share
ALA Quarterly Activities/Appendix 4C Cash Flow Report
28/07/25	PRICE SENSITIVE	720.46KB	Share
ALA Notification regarding unquoted securities - ALA
16/07/25		15.75KB	Share
ALA Notification of cessation of securities - ALA
07/07/25		12.75KB	Share
ALA Investor Presentation
02/07/25		3.31MB	Share
ALA Final Director's Interest Notice
01/07/25		254.77KB	Share
ALA Notice Under Section 708A
30/06/25		212.19KB	Share
ALA Retirement of Non-Executive Chairman
30/06/25		198.51KB	Share
ALA Application for quotation of securities - ALA
27/06/25		15.5KB	Share
ALA Notice Under Section 708A
24/06/25		252.11KB	Share
ALA Application for quotation of securities - ALA
23/06/25		15.49KB	Share
ALA Notice Under Section 708A
17/06/25		212.3KB	Share
ALA Notification of cessation of securities - ALA
17/06/25		12.88KB	Share
ALA Notification of cessation of securities - ALA
17/06/25		12.88KB	Share
ALA Notification of cessation of securities - ALA
17/06/25		12.88KB	Share
ALA Application for quotation of securities - ALA
17/06/25		15.79KB	Share
ALA Application for quotation of securities - ALA
17/06/25		15.79KB	Share
ALA Application for quotation of securities - ALA
17/06/25		15.8KB	Share
ALA Results of Extraordinary General Meeting
08/05/25		216.56KB	Share
ALA ALA exclusive iNKT technology option with Baylor
05/05/25		253.69KB	Share
ALA Investor webinar presentation
29/04/25		3.66MB	Share
ALA Notification regarding unquoted securities - ALA
24/04/25		16.44KB	Share
ALA Quarterly Update Webinar
16/04/25		182.74KB	Share
ALA Quarterly Activities/Appendix 4C Cash Flow Report
16/04/25	PRICE SENSITIVE	790.01KB	Share
ALA Notice of Extraordinary General Meeting/Proxy Form
10/04/25		896.41KB	Share
ALA Cancel - Proposed issue of securities - ALA
01/04/25		14.87KB	Share
ALA Cancel - Proposed issue of securities - ALA
01/04/25		14.88KB	Share
ALA Notification of cessation of securities - ALA
27/03/25		12.84KB	Share
ALA Quotation of Options
26/03/25		234.73KB	Share
ALA Application for quotation of securities - ALA
26/03/25		16.7KB	Share
ALA Proposed issue of securities - ALA
26/03/25		14.83KB	Share
ALA Prospectus
26/03/25		391.66KB	Share
ALA S&P DJI Announces March 2025 Quarterly Rebalance
07/03/25	PRICE SENSITIVE	174.42KB	Share
ALA Top 20 Holders and Range of Units for Attaching Options
05/03/25		82.61KB	Share
ALA Application for quotation of securities - ALA
05/03/25		19.09KB	Share
ALA Application for quotation of securities - ALA
05/03/25		15.75KB	Share
ALA Research Agreement with University of North Carolina
03/03/25	PRICE SENSITIVE	198.83KB	Share
ALA Letter from Managing Director and CEO
03/03/25		131.35KB	Share
ALA Half Year Report and Appendix 4D
27/02/25	PRICE SENSITIVE	3.35MB	Share
ALA Reinstatement to Official Quotation
26/02/25	PRICE SENSITIVE	85.89KB	Share
ALA Proposed issue of securities - ALA
26/02/25		14.82KB	Share
ALA Proposed issue of securities - ALA
26/02/25		16.52KB	Share
ALA Cancel - Proposed issue of securities - ALA
26/02/25		15.48KB	Share
ALA Prospectus
26/02/25	PRICE SENSITIVE	391.86KB	Share
ALA Arovella $15m Placement to fund Phase 1
26/02/25	PRICE SENSITIVE	274.83KB	Share
ALA Voluntary Suspension
10/02/25	PRICE SENSITIVE	718.43KB	Share
ALA Trading Halt
06/02/25	PRICE SENSITIVE	268.69KB	Share
ALA Notification of cessation of securities - ALA
04/02/25		12.84KB	Share
ALA Application for quotation of securities - ALA
04/02/25		15.57KB	Share
ALA Investor Presentation - Euroz Hartleys Healthcare Forum
04/02/25		3.54MB	Share
ALA Quarterly Activities/Appendix 4C Cash Flow Report
31/01/25	PRICE SENSITIVE	613.43KB	Share
ALA Update - Proposed issue of securities - ALA
30/01/25		15.37KB	Share
ALA Notice Under Section 708A
20/01/25		684.91KB	Share
ALA Application for quotation of securities - ALA
20/01/25		15.56KB	Share
ALA Notice Under Section 708A
14/01/25		176.33KB	Share
ALA Application for quotation of securities - ALA
14/01/25		15.56KB	Share
ALA Proposed issue of securities - ALA
10/01/25		15.42KB	Share
ALA Arovella $20m Placement - fully funded to complete Phase 1
10/01/25	PRICE SENSITIVE	267.39KB	Share
ALA Trading Halt
08/01/25	PRICE SENSITIVE	789.72KB	Share
ALA Release of Shares from Escrow
06/12/24		667.18KB	Share
ALA Change of Director's Interest Notice x5
29/11/24		876.7KB	Share
ALA Notification regarding unquoted securities - ALA
26/11/24		16.9KB	Share
ALA Notice Under Section 708A
15/11/24		213.96KB	Share
ALA Application for quotation of securities - ALA
15/11/24		15.56KB	Share
ALA Results of Annual General Meeting
15/11/24		219.36KB	Share
ALA AGM Chairman's Address and CEO & MD Presentation
15/11/24		3.17MB	Share
ALA Notice Under Section 708A
13/11/24		213.17KB	Share
ALA Application for quotation of securities - ALA
13/11/24		15.57KB	Share
ALA AusBioInvest Presentation
29/10/24		2.48MB	Share
ALA Quarterly Activities/Appendix 4C Cash Flow Report
29/10/24	PRICE SENSITIVE	958.06KB	Share
ALA Arovella receives R&D tax rebate of $3.0 million
25/10/24	PRICE SENSITIVE	196.37KB	Share
ALA Notice Under Section 708A
24/10/24		214.15KB	Share
ALA Application for quotation of securities - ALA
24/10/24		15.56KB	Share
ALA Notice Under Section 708A
18/10/24		213.21KB	Share
ALA Application for quotation of securities - ALA
18/10/24		15.56KB	Share
ALA Notice Under Section 708A
16/10/24		213.17KB	Share
ALA Application for quotation of securities - ALA
16/10/24		15.56KB	Share
ALA Investor Presentation
16/10/24		4.75MB	Share
ALA Clinical Advisory Board established
14/10/24		238.64KB	Share
ALA Notice of Annual General Meeting/Proxy Form
09/10/24		741.68KB	Share
ALA Notification regarding unquoted securities - ALA
07/10/24		15.71KB	Share
ALA Release of Shares from Escrow
01/10/24		231.97KB	Share
ALA Notification regarding unquoted securities - ALA
19/09/24		16.82KB	Share
ALA Application for quotation of securities - ALA
19/09/24		17.7KB	Share
ALA Investor Webinar Presentation
18/09/24		3.8MB	Share
ALA Becoming a substantial holder
18/09/24		164.73KB	Share
ALA Change in substantial holding
18/09/24		194.55KB	Share
ALA Updated Investor Webinar Presentation
12/09/24		239.74KB	Share
ALA Investor Webinar Presentation
12/09/24		237.06KB	Share
ALA 2024 ESG Report
11/09/24		405.46KB	Share
ALA ALA presents at Cell and Gene Therapy World Asia Conference
10/09/24		3.61MB	Share
ALA Corporate Governance Statement
22/08/24		209.37KB	Share
ALA Appendix 4G
22/08/24		268.71KB	Share
ALA Appendix 4E and Annual Report
22/08/24	PRICE SENSITIVE	5.2MB	Share
ALA Positive pre-IND feedback from FDA for ALA-101
07/08/24	PRICE SENSITIVE	203.16KB	Share

REFRESH

1 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 10.0¢		Change -0.005(4.76%)		Mkt cap ! $119.2M

Open	High	Low	Value	Volume
10.5¢	10.5¢	10.0¢	$12.74K	124.5K

Buyers (Bids)

No.	Vol.	Price($)
12	466255	10.0¢

Sellers (Offers)

Price($)	Vol.	No.
10.5¢	490175	10

View Market Depth

No.	Vol.	Price($)
12	466255	0.100
2	54811	0.099
7	181339	0.098
3	146855	0.097
1	105000	0.096

Price($)	Vol.	No.
0.105	490175	10
0.110	865044	6
0.115	216947	3
0.120	170451	6
0.125	310476	3

Last trade - 11.25am 11/08/2025 (20 minute delay)


Last 10.0¢		Change -0.005 ( 0.00 %)
Open	High	Low	Volume
10.5¢	10.5¢	10.0¢	329999
Last updated 11.28am 11/08/2025 ?

ALA (ASX) Chart

AROVELLA THERAPEUTICS LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories